Answers are grounded in this paper and cite their sources.
This study aims to analyze the financial ratios of PT. Kalbe Farma, Tbk. as a comprehensive measure of the company’s financial performance over the 2020–2024 period, a span that encompasses the COVID-19 pandemic, post-pandemic recovery, and a period of macroeconomic normalization. The financial ratios examined include the Liquidity Ratio (Current Ratio and Quick Ratio), Activity Ratio (Total Asset Turnover), Solvency Ratio (Debt to Assets Ratio and Debt to Equity Ratio), and Profitability Ratio (Gross Profit Margin, Net Profit Margin, Return on Assets, and Return on Equity). This study employs a descriptive-quantitative approach with secondary data sourced exclusively from the company’s audited consolidated annual reports and the Indonesia Stock Exchange (IDX). Data were collected through documentation techniques and analyzed using longitudinal financial ratio analysis methods. The results show that PT. Kalbe Farma, Tbk. consistently maintained a healthy financial condition across all four ratio categories throughout the observation period. Liquidity remained exceptionally strong, with the Current Ratio consistently exceeding 377%. The solvency structure was conservative, with the Debt to Assets Ratio never surpassing 20%. Profitability indicators experienced moderate pressure during 2022–2023 due to rising raw material costs and exchange rate volatility, but demonstrated clear signs of recovery by 2024. Asset efficiency, as measured by the Total Asset Turnover ratio, showed an improving trend over the five-year period. These findings underscore PT. Kalbe Farma, Tbk.’s resilient financial management and its capacity to sustain sound performance amid challenging external conditions.
No takes yet. Share an insight, caveat, or question.
Soekila et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: